Receptor-independent G protein activation may account for the stimulatory effects of first-generation H-1-receptor antagonists in HL-60 cells, basophils, and mast cells

被引:23
作者
Burde, R [1 ]
Dippel, E [1 ]
Seifert, R [1 ]
机构
[1] FREE UNIV BERLIN, KLINIKUM BENJAMIN FRANKLIN, INST PHARMAKOL, D-14195 BERLIN, GERMANY
关键词
Ca2+ influx; G-proteins; H-1-receptor antagonists; HL-60 leukemic cells; pertussis toxin; rat basophilic leukemia (RBL 2H3) cells;
D O I
10.1016/0006-2952(95)02123-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The first-generation histamine Hi-receptor antagonists, chlorpheniramine (CPHE) and diphenhydramine (DPH),may activate histamine release from basophils and mast cells. Because CPHE and DPH are cationic-amphiphilic and because several substances with such physicochemical properties activate heterotrimeric regulatory guanine nucleotide-binding proteins (G-proteins) in a receptor independent manner, we asked the question of whether or; not H-1-receptor antagonists could be G-protein activators as well. In dibutyryl cAMP differentiated HL-60 cells, CPHE and DPH increased cytosolic Ca2+ concentration and azurophilic granule release in pertussis toxin (PTX)-sensitive manners. In HL-60 membranes, PTX sensitive stimulations of GTPase [E.C. 3.6.1.-] and binding of guanosine 5'-[gamma-thio]triphosphate by I-I, receptor antagonists were observed. CPHE and DPH also increased GTP hydrolysis by the purified PTX sensitive G-protein, transducin. In all-trans-retinoic acid-differentiated HL-60 cells and rat basophilic leukemia cells (RBL 2H3 cells), H-1-receptor antagonists induced, unlike in dibutyryl cAMP differentiated HL-60 cells, Ca2+ influx without Ca2+ mobilization from intracellular stores. CPHE and DPH also induced serotonin release from RBL 2H3 cells. Our data indicate that first-generation H-1-receptor antagonists are receptor-independent G-protein activators and that such a mechanism of action accounts for their stimulatory effects in HL 60 cells, basophils, and mast cells.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 38 条
[1]  
Absolom D R, 1986, Methods Enzymol, V132, P95
[2]  
BARRETT KE, 1991, HDB EXP PHARM, V97, P93
[3]  
BUEB JL, 1990, MOL PHARMACOL, V38, P816
[4]   INHIBITION OF HISTAMINE-RELEASE FROM HUMAN-LUNG INVITRO BY ANTIHISTAMINES AND RELATED DRUGS [J].
CHURCH, MK ;
GRADIDGE, CF .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 69 (04) :663-667
[5]  
DEMAUREX N, 1992, J BIOL CHEM, V267, P2318
[6]  
ERBECK K, 1993, J IMMUNOL, V150, P1913
[7]   CA2+ AND MN2+ INFLUX THROUGH RECEPTOR-MEDIATED ACTIVATION OF NONSPECIFIC CATION CHANNELS IN MAST-CELLS [J].
FASOLATO, C ;
HOTH, M ;
MATTHEWS, G ;
PENNER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :3068-3072
[8]   THE MECHANISM OF INHIBITION OF ALKYLAMINES ON THE MAST-CELL PEPTIDERGIC PATHWAY [J].
FISCHER, T ;
BRONNER, C ;
LANDRY, Y ;
MOUSLI, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1176 (03) :305-312
[9]   HISTAMINE RECEPTOR-DEPENDENT AND/OR RECEPTOR-INDEPENDENT ACTIVATION OF GUANINE-NUCLEOTIDE-BINDING PROTEINS BY HISTAMINE AND 2-SUBSTITUTED HISTAMINE DERIVATIVES IN HUMAN LEUKEMIA (HL-60) AND HUMAN ERYTHROLEUKEMIA (HEL) CELLS [J].
HAGELUKEN, A ;
GRUNBAUM, L ;
KLINKER, JF ;
NURNBERG, B ;
HARHAMMER, R ;
SCHULTZ, G ;
LESCHKE, C ;
SCHUNACK, W ;
SEIFERT, R .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (07) :901-914
[10]  
HAGELUKEN A, 1995, N-S ARCH PHARMACOL, V351, P305